![Georges Mari](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Georges Mari has worked as a Financial Consultant & Asset Manager at Rossier, Mari & Associates AG since 1994, which he also founded in the same year.
Postes actifs de Georges Mari
| Sociétés | Poste | Début |
|---|---|---|
Rossier, Mari & Associates AG
 Rossier, Mari & Associates AG Investment ManagersFinance RMA utilizes a top-down investment approach in their goal to deliver long-term steady growth. Investment decisions are based on in-depth market analysis, future trends and market psychology factors. The firm also incorporates technical analysis when determining asset allocation in relation to market conditions and client requirements. In general, liquid assets are favored, with some shares and a small percentage of bonds. Preferred investment sectors are technology and energy with some value stocks and pharmaceutical/chemical/biotech. They invest in innovative sectors but do not deal in derivatives. | Fondateur | 01/01/1994 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Rossier, Mari & Associates AG
Rossier, Mari & Associates AG Investment ManagersFinance RMA utilizes a top-down investment approach in their goal to deliver long-term steady growth. Investment decisions are based on in-depth market analysis, future trends and market psychology factors. The firm also incorporates technical analysis when determining asset allocation in relation to market conditions and client requirements. In general, liquid assets are favored, with some shares and a small percentage of bonds. Preferred investment sectors are technology and energy with some value stocks and pharmaceutical/chemical/biotech. They invest in innovative sectors but do not deal in derivatives. | Finance |
